RXST RxSight, Inc.
$4.90▲ +0.00%
Healthcare
Other
After hours
$4.78▼ -2.53%
Oct 28, 4:46 PM ET
Volume 787.8K
Avg Volume (10D) 601.2K
Key Metrics & Fundamentals
Market Cap
$203.81M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.40 - 13.22
% vs 50 MA
-9.93%
% vs 200 MA
-23.61%
RSI-14
47.3
MACD Histogram
+0.0800
Beta (1Y vs SPY)
1.06
Free Cash Flow
-$11.49M
Gross Rev
$33.74M
Gross Profit
$25.89M
EBITDA
-$11.01M
COGS
$7.86M
Operating Exp
$39.66M
Operating Income
-$13.77M
EBIT
-$13.77M
Pretax Income
-$12.01M
Net Income
-$12.10M
EPS (Diluted)
-0.29
Price & Volume History
Loading chart…
Recent News

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
GlobeNewswire · Oct 23, 2026 8:00 PM ET

RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
GlobeNewswire · Oct 20, 2026 4:05 PM ET

RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
GlobeNewswire · Oct 19, 2026 9:00 AM ET
RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says
MT Newswires · Sep 23, 2026 10:42 AM ET
BofA Adjusts Price Target on RxSight to $5.50 From $6.50
MT Newswires · Sep 22, 2026 8:32 AM ET

RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
GlobeNewswire · Aug 26, 2026 4:15 PM ET

Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?
Insider Monkey · Aug 13, 2026 6:49 PM ET

RxSight (RXST) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 7:01 PM ET
Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 519% Upside
GuruFocus.com · Aug 6, 2026 9:21 AM ET
RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ...
GuruFocus.com · Aug 6, 2026 1:10 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See RXST's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.